Kintara Therapeutics Inc (NASDAQ:KTRA)

0.6568
Delayed Data
As of 3:55pm ET
 -0.0431 / -6.16%
Today’s Change
0.66
Today|||52-Week Range
3.35
-48.69%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Kintara Therapeutics Inc have a median target of 5.00, with a high estimate of 6.00 and a low estimate of 3.00. The median estimate represents a +661.27% increase from the last price of 0.66.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Kintara Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.16
Sales
$0.00
Reporting Date
Feb 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 36.00%
 
 
 
 
 
 
Growthannually 63.63%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.